TOMORROW - Register today: Learn more about radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Registration link: https://ow.ly/IX7l50Y0fUI

PUB ALERT: A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41324555/

PUB ALERT: Driving progress in recurrent and metastatic head and neck cancer: the NRG oncology perspective - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41627880/

Learn more about radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/IX7l50Y0fUI

Happy International Women and Girls in Science Day! Today we celebrate the brilliant women and girls who are breaking barriers, leading discoveries, and shaping the future through science and research.

TODAY! ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/Roy050XTlTz

PUB ALERT: Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41063518/

If you are attending the Multidisciplinary H&N Cancer Symposium next week, be sure to stop by the NRG-HN014 Investigators Meeting. in Directors Room B!

Today is #WorldCancerDay - a day focused on the importance of early detection and the need to support and fund research aimed towards a cure. #WorldCancerDay 💜

Today we celebrate our women physicians on the birthday of Dr. Blackwell. We greatly appreciate the contributions and achievements of the women on the frontlines of our clinical research. #NationalWomenPhysiciansDay

ONE WEEK AWAY! ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/8AOp50XTlTb

February is #CancerPreventionMonth - Please be sure to start conversations with your doctor and look into the various measures you can take to help reduce your cancer risk.

We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ

Did you know more information on the recently opened RTOG 3523 trial for progressive intracranial grade 1-3 meningioma is available on our website? Protocol documents are also available behind the login. https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523

ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8

NRG-BN001, NRG-GU005, NRG-GU006... all featured in the #NRG2026 Scientific Session today! Stop by to hear about these results and more at 3:00PM PT.

The #NRG2026 General Session is a great opportunity to hear the many updates coming out of the NRG committees and centers. Stop by this session at 12PM PT today.

We are SO thankful for our wonderful RTOG Foundation Communications Interns and all they are doing on the ground at #NRG2026! From video interviews, social media coverage, and more. We are lucky to have them.

TONIGHT at #NRG2026 in San Francisco join us for updates on our Foundation plus networking with refreshments. We'll be in the Hilton San Francisco Union Square Plaza B. Doors open at 6:45pm and presentations start at 7pm.

We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ

Starting at 1PM ET today! Learn about digital engagement and the impact it makes in clinical research from both the patient and physician perspectives (Registration required via #NRG2026). More info on NRG Meeting virtual sessions: https://ow.ly/AlM250Y0fum

ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8

PUB ALERT: Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40829719/

Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41436315/

Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting in Plaza B. Come by to network & hear updates on what RTOGF has been up to this year. @NRGOnc

ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8

Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40752652/

We look forward to all we can build together and the changes we can make through our research together in 2026. Have a happy and safe holiday. RTOG Foundation will reopen tomorrow, January 2nd.

Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting. Come by to network & hear updates on what RTOGF has been up to this year.

We want to wish everyone a happy and safe holiday season. This is a reminder that we will be closed starting today, December 24th at 12pm ET. We will reopen on January 2nd. Please note that we will have limited staff available during this time.

PUB ALERT: Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41343184/

With the holiday season, fast approaching we want to acknowledge our upcoming office closures. We will be closed starting December 24th at 12pm ET. We will reopen on January 2nd. Please note that we will have limited staff available during this time.

Attending #SABCS25? Be sure to check out today's presentation on RadComp during Rapid Fire 6 in Hemisfair 1-2 today!

PUB ALERT: Phase 3 Trial of Dose-Escalated RT & Standard Androgen Deprivation Therapy Versus Dose-Escalated RT and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115) - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41189315/

Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting. Come by to network & hear updates on what RTOGF has been up to this year.

Did You Know? There are several ways you can participate in RTOG Foundation as a member site, an industry collaborator, or by enrolling in one of our studies. Read more on our website about how you can partner with RTOG Foundation. Learn more at http://RTOG.org/Partners

RTOG 3521, also known as the "TRANSPARENT" study, is evaluating the role of combo chemo-immunotherapy in patients w/ #NasopharyngealCancer - Study information is available on our website as well as study documents (behind login): https://www.rtog.org/Clinical-Trials/Foundation-Studies/3521

Have you heard of the NRG-GU015 “ARCHER” study assessing shorter duration RT for patients receiving chemotherapy for bladder cancer? The Study PIs will be hosting a webinar with a Q&A for sites on Friday, December 12, 2025 1:00-2:00 PM ET - Register at https://ow.ly/5i3L50X9MMg )

Happy Thanksgiving to all! We are incredibly thankful for our researchers, sites, staff, and the patients who advocate for continued improvements in clinical research and those who have or are participating in our trials. We wish all a happy and safe holiday.

Reminder: Please note RTOG's operational hours during the upcoming Thanksgiving holiday.

Planning on attending the #NRG2026 Winter Meeting in San Francisco? I know we are! Be sure to register before the deadline passes. Learn more: https://www.nrgoncology.org/Winter2026Mtg

Please note RTOG's operational hours during the upcoming Thanksgiving holiday.

Did you know more information on the recently opened RTOG 3523 trial for progressive intracranial grade 1-3 meningioma is available on our website? Protocol documents are also available behind the login. www.rtog.org/Clinical-Tri...

November is #PancreaticCancerAwarenessMonth - RTOG Foundation past publications on pancreatic cancer research can be found on our website https://rtog.org/Clinical-Trials/Publications as well as on the NRG website https://nrgoncology.org/Clinical-Trials/Publications/Publication-Search#PancreaticCancerAwarenessMonth

PUB ALERT: Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41189315/

Happy #VeteransDay - Thank you to all who have served and continue to serve.

#FamilyCaregiverAwarenessMonth raises awareness and share resources and support for those fighting alongside their loved ones who are impacted by cancer. Thank you for all that you do!

PRESS RELEASE & TRIAL ACTIVATION: RTOG Foundation Opens New Study Testing [177Lu]Lu-DOTA-TATE for Adults with Meningioma - Read the release: https://ow.ly/BiLA50Xmria - Study info at https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523

In case you missed it, earlier this month we noted just how important our RTOGF Communications Interns are to growing our message! Learn more about our 2025-2026 interns, Dr. Lee and Dr. Narvaez here: ow.ly/fyva50X7Q2q - Thank you for all you do!

Our RTOGF Interns interviewed Dr. Stephen Chun - Director of Radiation Oncology Clinical Research at MD Anderson Houston area locations and co-founder of the NRG Oncology Podcast - on his career & advice for early career investigators. Read more: ow.ly/PvaF50X7Ttn